果皮作为一种可食用的基生物活性化合物来源,具有抗糖尿病和抗糖化特性
Javier Cano-Lou1,2, Adrián Millán-Laleona1,2, Rares Candrea1
1Department of Pharmacy, Faculty of Health Sciences, Universidad San Jorge, 50830, Zaragoza, Spain. ilopez@usj.es.
Food & function
|March 11, 2025
概括
果皮含有丰富的类化合物,提供潜在的抗糖尿病益处. 提取物显示出抗氧化,抗糖和酶抑制特性,在细胞培养物中没有观察到细胞毒性.
科学领域:
- 食品科学 食品科学 食品科学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 果 (Malus domestica) 在全球范围内被消费,产生大量的皮废物.
- 果皮含有类生物活性化合物,具有潜在的健康益处,包括预防2型糖尿病.
研究的目的:
- 探索果皮作为用于预防2型糖尿病的类化合物的来源.
- 为了评估果皮提取物的抗糖尿病,抗糖和抗氧化特性.
主要方法:
- 从六种果品种中提取了烯化合物,使用超声波与甲醇.
- 使用HPLC-MS/MS.进行37个单个化合物的量化.
- 在体外测试中评估了酶抑制 (α-葡萄糖酶,α-氨酶,胰腺脂酶),抗糖化,抗氧化活性和细胞毒性 (Caco-2细胞中的MTT测试).
主要成果:
- 鉴定到的关键化合物包括高化物,化物3,5-二甲化物,化酸,化物,化物,化物和化物B2.
- 所有的提取物都表现出了先进的糖化最终产品的剂量依赖中和和抗激素活性.
- 四种品种抑制了α-葡萄糖酶;一种品种 ("Amarilla de Octubre") 抑制了胰腺α-氨基酶.
- 在生理度下,在Caco-2细胞中没有观察到细胞毒性.
结论:
- 果皮是生物活性化合物的宝贵来源,具有显著的抗糖尿病,抗糖化和抗氧化潜力.
- 这些发现支持将果皮作为一种功能性成分用于治疗2型糖尿病.
更多相关视频
07:05Author Spotlight: Eco-Friendly Extraction of Bioactive Compounds Using Polyol-Based Microwave-Assisted Techniques
Published on: August 23, 2024
1.4K
10:30A Generalized Method for Determining Free Soluble Phenolic Acid Composition and Antioxidant Capacity of Cereals and Legumes
Published on: June 10, 2022
6.7K
相关概念视频
Fruit Development, Structure, and Function
21.9K
Fruits form from a mature flower ovary. As seeds develop from the ovules contained within, the ovary wall undergoes a series of complex changes to form fruit. In some fruits, such as soybeans, the ovary wall dries; in other fruits, such as grapes, it remains fleshy. In some cases, organs other than the ovary contribute to fruit formation; such fruits are called accessory fruits.
21.9K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
141
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
141
Introduction to Plant Diversity
43.5K
From Water to Land
43.5K
